ECL vs LLY · P/E 35, rev $4.01B vs P/E 39, rev $65.18B
Ecolab Inc (ECL) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ECL and LLY stock pages for the full models.
Not investment advice.